Prospective longitudinal study reveals increasing treatment effects over time in patients with refractory angina pectoris, suggesting cumulative benefits.
This study helps to resolve the debate on SCS efficacy in patients with RAP. There were significant quantitative increases in all treatment effects over time, suggesting cumulative physiological mechanisms that mandate sufficient follow-up in clinical trials to fully assess outcomes.
No takes yet. Share an insight, caveat, or question.
Teresa Rusicka (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: